Business
Math Over Myth: MindMed’s Self Destructive Stock Mission
Business, Stock ReportsPsychedelic stock MindMed enters free fall as news of a private equity offering of common stock spooks retail investors
Math Over Myth: Psychedelic Stock HAVN Life Collapses
Business, Stock ReportsThe psychedelic corporate shakeout continues as another company, HAVN Life Sciences, folds due to lack of cash flow
End of Life: Psychedelics in Palliative Care
Business, InterviewsWe interview Dr. Paul Thielking, Chief Science Officer of Numinus, about the use of psychedelics in palliative care and end of life care
Math Over Myth: Spotlight on MindMed
Business, Stock ReportsIn the latest installment of Math Over Myth we navigate psychedelic stock MindMed’s reverse split with Fibonacci numbers
Math Over Myth: Spotlight on Psychedelic Stocks ATAI & COMPASS
Business, Stock ReportsIf you want to invest in psychedelic stocks, ignore the hype and look at the technicals. We take a deep dive on atai Life Sciences & COMPASS Pathways
Psychedelic Stocks: ARK Invest and the Reverse Midas Touch
Business, Investing, Stock ReportsCathie Wood is buying up stocks from the most dubious actors in the psychedelic sector. Given ARK Invest’s subpar performance, is that a good thing?
Psychedelic Stocks: MindMed and atai Slash their Pipelines, Mydecine Collapses
Business, Stock ReportsThe psychedelic renaissance hits a rough patch as major companies look to tighten their belts or face total collapse. What’s happening with Psychedelic Stocks?
MindMed Shelves 18-MC for Opioid Use Disorder and Further Cuts Pipeline
Business, Stock ReportsMindMed drops its proprietary ibogaine for opioid addiction research amidst an ongoing shakeup. What is going on with this psychedelics company?